CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 191 enrolled
Drug / intervention
Aspirin enteric coated pellests 100mgdrug
Likely dose
Aspirin enteric coated pellests 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00386529
NCT00386529Phase 4Completed
CompareCT.gov

A Multi-center, Double-Blind Randomized, Cross-over, Active-control, Comparative Clinical Study to Evaluate the Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-Controlled Hypertensive Patients (Phase IV)

Boryung Pharmaceutical Co., Ltd·interventional·Posted Oct 11, 2006·Updated Dec 15, 2010

In Brief

A Phase 4 clinical trial evaluating Aspirin enteric coated pellests 100mg for Well-controlled Hypertension. Completed, enrolled 191 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the influence of aspirin on blood pressure in well-controlled hypertensive patients who receive low dose aspirin at different times of the day

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWell-controlled Hypertension
CountriesSouth Korea
CollaboratorsKyungpook National University Hospital, The Catholic University of Korea, Cheil General Hospital and Women's Healthcare Center, Inje University, Keimyung University, Seoul National University Bundang Hospital, Severance Hospital, Yeungnam University Hospital

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 11, 2006
Enrollment StartSep 1, 2006
Primary CompletionJan 1, 2007
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 19.7 years ago

Interventions

Aspirin enteric coated pellests 100mgdrug